As described above, there is compelling evidence that significant tissue-level cobalamin deficiency is present in some companion animal patients with gastrointestinal disease
Benefits for People With Type 2 Diabetes People with type 2 diabetes saw two noticeable improvements: Lower blood sugar levels , including meaningful HbA1c reductions Steady weight loss , though typically a little less than non-diabetic participants a pattern also seen with injected GLP-1 receptor agonists The blood sugar improvements reflect how GLP-1 receptor agonists support insulin activity and slow digestion, which may help stabilise glucose throughout the day
This article provides educational information about how these medications work, potential considerations when used together, and guidance on monitoring your health if prescribed both treatments
Gould E, Vail N, Wagers M, Gross CG
What do GLP-1 drugs actually do to your body
& Puzianowska-Kuznicka, M